CTVA vs PCSA · P/E 42, rev $16.91B vs $5.9M cap
Corteva Inc (CTVA) versus Processa Pharmaceuticals Inc (PCSA) — a side-by-side from cached financials, not a winner call.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
Processa Pharmaceuticals Inc (PCSA) is a biotechnology company listed on NASDAQ.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
PCSA does not have a complete income-statement cache yet.
CTVA currently screens at market cap $51.52B and trailing P/E 41.6. PCSA currently screens at market cap $5.9M.
Not investment advice. Open the CTVA and PCSA stock pages for the full models.
Not investment advice.